Table 5 Potential risk factors independently associated with vascular complications in diabetic patients

Age (years)

1.03 (0.99–1.08)

0.147 ^NS

–

–

Sex (male)

1.09 (0.58–2.05)

0.791 ^NS

–

–

Smoking

1.23 (0.66–2.33)

0.515 ^NS

–

–

Hypertension

1.19 (0.53–2.67)

0.673 ^NS

–

–

Dyslipidemia

3.66 (0.42–31.93)

0.240 ^NS

–

–

Duration of DM(years)

1.11 (0.93–1.33)

0.242 ^NS

–

–

PAI-1 genotypes:

–

0.018 ^S

–

–

Genotype (5G/5G)

Ref. (1.00)

–

–

–

Genotype (4G/5G)

3.55 (1.47–8.56)

0.005 ^HS

–

–

Genotype (4G/4G)

2.54 (1.01–6.37)

0.047 ^S

–

–

Dominant: (4G/4G + 4G/5G)

3.09 (1.33–7.17)

0.009 ^HS

–

–

PAI-1

1.06 (1.04–1.08)

< 0.001 ^HS

1.06 (1.03–1.09)

< 0.001 ^HS

TAFI

1.04 (1.03–1.05)

< 0.001 ^HS

–

–

d-dimer (mg/dl)

1.58 (1.20-2.07)

< 0.001 ^HS

–

–

BMI (kg/m³)

0.97 (0.89-1.06)

0.483 ^NS

–

–

FBS (mg/dl)

1.01 (1.00-1.03)

0.034 ^S

1.00 (0.99–1.02)

0.871 ^NS

2Hr PBS (mg/dl)

1.01 (1.00-1.03)

0.007 ^S

–

–

T.C (mg/dl)

1.01 (1.00-1.03)

0.083 ^NS

1.00 (0.98–1.01)

0.646 ^NS

Triglycerides (mg/dl)

1.02 (1.01-1.03)

0.006 ^S

1.01 (1.00–1.03)

0.107 ^NS

LDL (mg/dl)

1.00 (0.98-1.01)

0.680 ^NS

–

–

HDL (mg/dl)

1.16 (1.09-1.24)

< 0.001 ^HS

1.18 (1.11–1.26)

< 0.001 ^HS